Map2k1 Antibody - N-terminal region
| Product name: | Map2k1 Antibody - N-terminal region |
| Source: | Rabbit |
| Purity: | >95% |
| Buffer Formulation: | phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. |
| Applications: | WB |
| Storage: | Aliquot and store at -20°C. Avoid repeated freeze / thaw cycles |
| UOM: | 100ug |
Rabbit anti-Map2k1 Antibody - N-terminal region
Catalog Number:IC118687
Product Profile
| ProductName | Rabbit anti-Map2k1 Antibody - N-terminal region |
|---|---|
| AntibodyType | Primary Antibodies |
| Immunogen |
The immunogen for Anti-Map2k1 antibody is: synthetic peptide directed towards the N-terminal region of Mouse Map2k1 |
Key Feature
| Clonality | Polyclonal |
|---|---|
| Isotype | IgG |
| Host Species | Rabbit |
| Tested Applications | |
| Species Reactivity | |
| Concentration | 1mg/ml |
| Purification | Affinity purified |
Target Information
| Gene Symbol | Map2k1 |
|---|---|
| Gene Synonyms |
MAPKK1
More
MEKK1 Mek1 Prkmk1 |
| Gene Full Name | mitogen-activated protein kinase kinase 1 |
| Gene Summary |
Map2k1 is a dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway.Binding of extracellular ligands such as growth factors, cytokines and hormones to their cell-surface receptors activates RAS and this initiates RAF1 activation.
More
|
| Alternative Names |
MAPKK1
More
MEKK1 Mek1 Prkmk1 |
| MolecularWeight(MW) | 43kDa |
| Sequence | 393 amino acids |
Database Links
| Entrez Gene | 26395 |
|---|---|
| SwissProt ID | P31938 |
| Protein Accession | NP_032953 |
Application
-
Western blot
Host: Rabbit
Target Name: Map2k1
Sample Tissue: Mouse Liver lysates
Antibody Dilution: 1.0ug/ml
Additional Information
| Form | Liquid |
|---|---|
| Storage Instructions | Aliquot and store at -20°C. Avoid repeated freeze / thaw cycles |
| Storage Buffer | phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. |
Note: The product is for research use only,not for use in diagnostic or therapeutic procedures.












